HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

W Fraser Symmans Selected Research

W Fraser Symmans Research Topics

Disease

72	Breast Neoplasms (Breast Cancer) 08/2015 - 05/2002
59	Neoplasms (Cancer) 09/2015 - 08/2002
9	Carcinoma (Carcinomatosis) 09/2015 - 08/2002
9	Residual Neoplasm 07/2015 - 04/2004
5	Neoplasm Metastasis (Metastasis) 11/2009 - 05/2002
2	Inflammatory Breast Neoplasms 05/2012 - 02/2011
2	Noninfiltrating Intraductal Carcinoma (DCIS) 07/2007 - 01/2006
1	Thymoma (Thymic Carcinoma) 05/2014
1	Adenocarcinoma 01/2013
1	Neutropenia 01/2013
1	Circulating Neoplastic Cells 04/2009
1	Ductal Carcinoma 10/2007
1	Lobular Carcinoma 11/2006
1	Colorectal Neoplasms (Colorectal Cancer) 10/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2004
1	Hematologic Neoplasms (Hematological Malignancy) 10/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2004

Drug/Important Bio-Agent (IBA)

26	Estrogens (Estrogen)FDA Link 02/2015 - 07/2003
15	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 04/2004
14	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 01/2003
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013 - 04/2003
10	Fluorouracil (Carac)FDA LinkGeneric 11/2010 - 04/2003
8	Messenger RNA (mRNA)IBA 01/2014 - 03/2004
7	Epidermal Growth Factor Receptor (EGF Receptor)IBA 05/2014 - 04/2004
7	taxaneIBA 01/2013 - 04/2007
7	HormonesIBA 02/2011 - 09/2003
6	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 01/2008
6	Tamoxifen FDA LinkGeneric 04/2013 - 04/2007
5	AnthracyclinesIBA 01/2013 - 04/2004
5	trastuzumab (Herceptin)FDA Link 01/2007 - 01/2003
4	RNA (Ribonucleic Acid)IBA 01/2014 - 10/2002
4	Proteins (Proteins, Gene)IBA 01/2011 - 09/2003
4	ParaffinIBA 05/2008 - 01/2003
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2014 - 01/2008
3	Phosphotransferases (Kinase)IBA 05/2014 - 11/2010
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2014 - 03/2008
3	TaxoidsIBA 01/2013 - 12/2008
3	tau Proteins (tau Protein)IBA 09/2009 - 06/2005
3	Complementary DNA (cDNA)IBA 01/2006 - 03/2003
3	Biological Markers (Surrogate Marker)IBA 01/2005 - 09/2003
3	Peptide Hydrolases (Proteases)IBA 03/2004 - 03/2003
2	dasatinib (BMS 354825)FDA Link 10/2014 - 05/2010
2	imatinib (Gleevec)FDA Link 05/2014 - 10/2004
2	Investigational DrugsIBA 05/2014 - 07/2012
2	Small Interfering RNA (siRNA)IBA 04/2014 - 11/2010
2	Phenobarbital (Luminal)FDA Link 01/2014 - 08/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2009 - 04/2004
2	docetaxel (Taxotere)FDA Link 12/2008 - 01/2003
2	Formaldehyde (Formol)FDA Link 05/2008 - 02/2004
2	Epirubicin (Ellence)FDA LinkGeneric 01/2007 - 06/2005
2	Eosine Yellowish-(YS) (Eosin)IBA 04/2004 - 08/2002
2	Hematoxylin (Haematoxylon)IBA 04/2004 - 08/2002
2	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2004 - 09/2003
2	Cell Adhesion MoleculesIBA 03/2004 - 09/2003
2	Transcription Factors (Transcription Factor)IBA 03/2004 - 09/2003
1	sunitinib (Sutent)FDA Link 05/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2014
1	Protein Kinase InhibitorsIBA 05/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2014
1	Sirolimus (Rapamycin)FDA Link 05/2014
1	tranilast (N 5')IBA 05/2014
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2013
1	letrozole (Femara)FDA LinkGeneric 01/2013
1	ixabepilone (BMS 247550)FDA Link 01/2013
1	CyclinsIBA 01/2013
1	TubulinIBA 01/2013
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2012
1	Monomeric GTP-Binding ProteinsIBA 02/2012
1	AntibodiesIBA 01/2011
1	Protein Kinases (Protein Kinase)IBA 11/2010
1	Aromatase (CYP19)IBA 09/2010
1	Alkylating AgentsIBA 01/2010
1	LipocalinsIBA 11/2009
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2009
1	Glycoproteins (Glycoprotein)IBA 11/2009
1	oblimersen (G3139)IBA 12/2008
1	Biological Tumor Markers (Tumor Markers)IBA 05/2008
1	Antineoplastic Agents (Antineoplastics)IBA 06/2006
1	bortezomib (Velcade)FDA Link 10/2004
1	cetuximab (Erbitux)FDA Link 10/2004
1	bevacizumab FDA Link 10/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2004
1	gefitinib (Iressa)FDA Link 10/2004
1	Topoisomerase InhibitorsIBA 04/2004
1	Phosphopyruvate Hydratase (Enolase)IBA 03/2004
1	First StepIBA 03/2004
1	Angiopoietin-1IBA 03/2004
1	Insulin-Like Growth Factor Binding Protein 5IBA 03/2004

Therapy/Procedure

48	Drug Therapy (Chemotherapy) 09/2015 - 08/2002
4	Neoadjuvant Therapy 09/2015 - 03/2008
3	Aftercare (After-Treatment) 09/2015 - 11/2002
3	Adjuvant Chemotherapy 02/2015 - 05/2004
3	Segmental Mastectomy (Lumpectomy) 05/2012 - 09/2006
3	Combination Drug Therapy (Combination Chemotherapy) 01/2012 - 01/2010
1	Lymph Node Excision (Lymph Node Dissection) 10/2013
1	Simple Mastectomy 03/2011
1	Mastectomy (Mammectomy) 03/2011
1	Individualized Medicine 04/2009
1	Chemoprevention 01/2006
1	Therapeutics 10/2004